Placeholder: cancer cell flooting cancer cell flooting

@TTF

Prompt

cancer cell flooting

1 year ago

Generate Similar

Explore Similar

Model

Kandinsky 2.2

Guidance Scale

7

Dimensions

4096 × 4096

Similar

group of T cells in red color and group of cancer cells in brown color
With immune checkpoint inhibitor therapy: Antibody binds to PD-1 or PD-L1 receptor Blocks interaction between PD-1 and PD-L1 Remove brakes on T cell activation Result: T cell fully activates upon tumor antigen recognition T cell divides and proliferates T cell releases cytokines and cytotoxic granules Tumor cell killed by immune response Unleashes anti-tumor immunity)
Immune cells and cancer cells
Immune cell expressing PD1 interacted with Cancer cell expressing PD-L1
1 cancer cell
Cancer immunotherapy has demonstrated significant potential as a cancer treatment by enhancing the immune system's ability to recognize and eliminate cancer cells. However, its efficacy can be limited by factors such as tumor heterogeneity, immunosuppressive tumor microenvironments, and systemic toxicities. Recent advances in drug delivery systems have facilitated the development of more targeted and personalized cancer therapies. Microneedles have emerged as a promising platform for non-invasiv
group of T cells
Stoma cell
Immune cells expressing PD1 interacted with Cancer cell expressing PDL-1
group of T cells and group of cancer cells with deferent colure
Immune cell expressing PD1 interacted with Cancer cell expressing PDL-1
a tricellular junction

© 2025 Stablecog, Inc.